QualityStocksNewsBreaks Archives - Page 335 of 1541

WednesdayOct 25, 2023 12:05 pm

QualityStocksNewsBreaks – Safety Shot (NASDAQ: SHOT) Granted Second U.S. Patent for JW-700 Treatment Designed for $1.5B Hair-Growth Market

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced a “significant milestone” in its development of treatments for androgenetic alopecia, or hair loss: the granting of a second U.S. patent issued for JW-700, a topical treatment designed to improve minoxidil’s efficacy. The patent was issued by the U.S. Patent and Trademark Office. The patent adds to the growing global intellectual property (“IP”) estate for Safety Shots Legacy products. According to the announcement, minoxidil is a common treatment of hair loss sold under brand names including Rogaine(R) and Hair Regrowth for Men(R), and Safety Shot’s JW-700 has been shown to…

WednesdayOct 25, 2023 10:45 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, has entered into a definitive agreement for the issue and sale of more than 3 million common shares, or prefunded warrants in lieu thereof. Specifically, the company agreed to a private placement of 3,012,049 common shares priced at $0.83 per share. In addition, the company entered an agreement for an associated preferred investment option as well as a definitive agreement regarding specific outstanding preferred investment options issued in November 2022. The announcement outlines specifics of the agreement. The company also…

TuesdayOct 24, 2023 12:20 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced its selection of a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s treatment model. InMed will be advancing cannabinoid analog INM-901 in its pharmaceutical drug development program. “The most recent studies of INM-901 demonstrate promising disease-modifying effects in an Alzheimer’s disease treatment model,” said Dr. Eric Hsu, InMed’s SVP of preclinical research and development. “We are optimistic that the next stage of studies will continue to show how…

TuesdayOct 24, 2023 12:09 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Top-Line Results from Phase 2a Trial Spotlighted in Latest NNA Release

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. The segment focuses on the company’s most recent announcement of its topline results from the CLEAR Mind phase 2a clinical trial of LGVN’s Lomecel-B(TM) for the treatment of mild Alzheimer's disease. According to the segment, the Lomecel-B study met its primary safety endpoint and is supported by lack of deterioration in cognitive or atrophy signals. The encouraging results will be used as a foundation…

TuesdayOct 24, 2023 11:41 am

QualityStocksNewsBreaks – GEMXX Corporation (GEMZ) Releases Gold Production Report for BC-Based Snow Creek Test Mine Site

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a 50% partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), has successfully completed its third and final clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining season. According to the announcement, GEMXX and CHMI have processed 31,200 cubic yards of gold-bearing ore during the 2023 test season; those results met all expectations, the report noted, and are positive considering much of the material used during the test program was surface “gold bearing ore” that had been stockpiled when making…

TuesdayOct 24, 2023 11:03 am

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Executes Initial Drill Program at Ruby Graphite Project

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) today announced completion of its 2023 phase one drill program at its Ruby Graphite Project near Dillon, Montana. The program’s impressive efficiencies allowed the company to complete 22 holes, surpassing the originally planned 16 holes, with all reaching an average depth of 150 meters. The company’s geological team is now focused on data compilation, with assay results expected in the first quarter of 2024. “The team is very pleased with how much we have been able to accomplish during phase one of our drill program,” said Paul Gorman, CEO of Reflex Advanced Materials.…

TuesdayOct 24, 2023 10:26 am

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Announces E! TV Founder as Newest Strategic Advisor, Becomes IBN Client Partner

Diamond Lake Minerals (OTC: DLMI), a leading multistrategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, has named a new strategic advisor: Larry Namer. Renowned for his influential contributions to cable television, live events, music and new media, Namer brings an impressive five decades of experience to his new responsibilities, including cofounding E! Entertainment Television. According to the announcement, he was the visionary behind Comspan Communications, a company he founded that played a fundamental role in introducing Western forms of entertainment to the former Soviet Union; Steeplechase Media, which was the primary consultant…

MondayOct 23, 2023 12:25 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Names Veteran Gaming, Sports & Entertainment Icon as Strategic Advisor

Diamond Lake Minerals (OTC: DLMI), a leading multistrategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, has announced a new strategic advisor: Michael J. Malik Sr. According to the announcement, Malik has 50-plus years of experience and a proven track record in the gaming, sporting and entertainment industry. Currently a principal at MJM Enterprises Development Company Inc., Malik has served as a partner in the Detroit Entertainment casino group that, under his direction, selected the Mandalay Bay group as a casino operator and built MotorCity Casino into a thriving entertainment hub that contributed…

MondayOct 23, 2023 11:10 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Update on Progress of Action Filed Against Key Broker Dealers

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on the status of the lawsuit it filed against TD Ameritrade, Charles Schwab, National Finance Services and others alleging that those broker dealers engaged in a scheme to manipulate the share price of the company’s securities. Mullen filed the lawsuit in August 2023 in the United States District Court in the Southern District of New York. The company is seeking compensatory damages and injunctive relief from the defendants “unlawful conduct in violation of Section 10b and Rule 10b-5 promulgated thereunder of the Securities Exchange Act of 1934.” Earlier…

FridayOct 20, 2023 3:42 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Committed to R&D, Eyeing Excellent Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator seeking to enhance the bioavailability of multiple active pharmaceutical ingredients using its patented DehydraTECH(TM) drug delivery technology platform. The company continues to devote an increasing proportion of its resources and focus toward research and development (“R&D”) as part of its overall goal to establish areas of investigation for commercial pursuits and reduce risks of the unknown for both commercial and regulatory endeavors. “In the three months ended May 31, 2023 (‘Q3 2023’), for example, the company increased its R&D expenses 118% year over year to $1.64 million from $752,095 in Q3…

Site Search

Company Search

Category: QualityStocksNewsBreaks